Atlas Trials

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH

Clinical trial NCT02972268 · COMPLETED

Trial details

NCT number
NCT02972268
Sponsor
Jeil Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lower Urinary Tract SymptomsBenign Prostatic Hyperplasia
Start date
2016-02-01
Primary completion
2017-11-02
Enrollment
780

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.